<DOC>
	<DOC>NCT00317239</DOC>
	<brief_summary>This study compares the efficacy and safety of intravenous (IV) iron (VIT45) versus oral iron (ferrous sulfate) administered to subjects who suffer from anemia and are diagnosed with non-dialysis dependent chronic kidney disease (NDD-CKD).</brief_summary>
	<brief_title>VIT45 Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease</brief_title>
	<detailed_description>This study compares the efficacy and safety of intravenous (IV) iron (VIT45) versus oral iron (ferrous sulfate) administered to subjects who suffer from anemia and are diagnosed with non-dialysis dependent chronic kidney disease (NDD-CKD).</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency, Chronic</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Males or females &gt; or = 12 years of age NDDCKD subjects Baseline hemoglobin &lt; or = 11g/dl Stable erythropoietin (EPO) status Known hypersensitivity to ferrous sulfate or IV iron Unstable EPO status Anemia not related to CKD Chronic, serious infection Recent IV iron Recent blood transfusion Recent blood loss Need for surgery Received investigational drug within 30 days Female subjects who are pregnant or lactating</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Anemia</keyword>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Iron</keyword>
</DOC>